Immunospot Technology India Private Limited
About Immunospot Technology India Private Limited
Data last updated:
Immunospot Technology India Private Limited is a foreign private limited company based in Hyderabad, Telangana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 03 January 2024.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74909TS2024FTC180744.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dhananjay Bhaskarrao Kulkarni (Non- Individual Subscriber) and Alexander Andreas Lehmann (Non- Individual Subscriber).
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.76 Cr. For the same year it recorded a net profit of ₹4.83 Lakh (net margin 2.7%) and EBITDA of ₹6.72 Lakh (EBITDA margin 3.8%).
Company details
Contact details
Immunospot Technology India Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressG – 311 Gulmohar Garden, Annex II Mallapur, Hyderabad, Telangana, India – 500076
- IndustryBusiness Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Immunospot Technology India Private Limited
FY 2025 filings availableImmunospot Technology India Private Limited reported revenue of ₹1.76 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹6.72 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹4.83 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.8% | |
| Net Profit Margin | 2.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Immunospot Technology India Private Limited, buy the company report.
Board of directors of Immunospot Technology India Private Limited
Immunospot Technology India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhananjay Bhaskarrao Kulkarni | Non- Individual Subscriber | 03 Jan 2024 | 2 Years 10 Months | Current |
| Alexander Andreas Lehmann | Non- Individual Subscriber | 03 Jan 2024 | 2 Years 10 Months | Current |
Peer comparison
Immunospot Technology India Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Skanda Surgicals & Pharma Private Limited | ₹1.78 Cr (FY 2022) | -36.0% | Bangalore, Karnataka, India | |||
| Dr. Vetrx Pharma Private Limited | ₹1.77 Cr (FY 2024) | 62.0% | Ahmedabad, Gujarat, India | |||
| Irimed Technologies Private Limited | ₹1.77 Cr (FY 2024) | 159.0% | Hyderabad, Telangana, India | |||
| Ra-Vish Wellness Private Limited | ₹1.77 Cr (FY 2025) | 183.0% | Pune, Maharashtra, India | |||
| Avant22 Implants Private Limited | ₹1.76 Cr (FY 2025) | 87.0% | Hyderabad, Telangana, India | |||
| Immunospot Technology India Private Limitedthis company | ₹1.76 Cr (FY 2025) | ₹4.83 Lakh | 2.7% | Hyderabad, Telangana, India | ||
| Cibanova Life Sciences Private Limited | ₹1.75 Cr (FY 2025) | -37.0% | Mumbai, Maharashtra, India | |||
| Pharma Test Instruments India Private Limited | ₹1.75 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Corium Medical Technologies Private Limited | ₹1.75 Cr (FY 2025) | -11.0% | Chennai, Tamil Nadu, India | |||
| Sanj Healthcare Private Limited | ₹1.75 Cr (FY 2023) | 32.0% | Guwahati, Assam, India | |||
| Laxminarayan Healthcare Private Limited | ₹1.74 Cr (FY 2025) | -23.0% | Delhi, India |
To see the full peer comparison of Immunospot Technology India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Immunospot Technology India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immunospot Technology India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Immunospot Technology India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Immunospot Technology India Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Alexander Andreas Lehmann was appointed as Non- Individual Subscriber on 03 Jan 2024.
Frequently asked questions
Immunospot Technology India is an active foreign private limited company based in Hyderabad, Telangana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 03 January 2024 (2+ years old) and is registered under CIN U74909TS2024FTC180744.
Immunospot Technology India has 2 current directors:
- Dhananjay Bhaskarrao Kulkarni - Non- Individual Subscriber
- Alexander Andreas Lehmann - Non- Individual Subscriber
The latest financial statements of Immunospot Technology India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Immunospot Technology India is U74909TS2024FTC180744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunospot Technology India was incorporated on 03 January 2024, making it 2+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Immunospot Technology India by revenue are Skanda Surgicals & Pharma Private Limited, Dr. Vetrx Pharma Private Limited, Irimed Technologies Private Limited, Ra-Vish Wellness Private Limited, Avant22 Implants Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Alexander Andreas Lehmann was appointed as Non- Individual Subscriber on 03 Jan 2024. Dhananjay Bhaskarrao Kulkarni was appointed as Non- Individual Subscriber on 03 Jan 2024.
The registered office of Immunospot Technology India is at G – 311 Gulmohar Garden, Annex II Mallapur, Hyderabad, Telangana, India – 500076.
Immunospot Technology India operates in the business services industry, in the miscellaneous business activities segment.
Immunospot Technology India can be reached at its registered office: G – 311 Gulmohar Garden, Annex II Mallapur, Hyderabad, Telangana, India – 500076.
Immunospot Technology India is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
